Leerink Partners Starts Atrium Therapeutics (RNA) at Outperform
(Updated - May 15, 2026 10:28 AM EDT)
Leerink Partners analyst Joseph Schwartz initiates coverage on Atrium Therapeutics (NASDAQ ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
Leerink Partners analyst Joseph Schwartz initiates coverage on Atrium Therapeutics (NASDAQ ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
